JP2012506237A5 - - Google Patents

Download PDF

Info

Publication number
JP2012506237A5
JP2012506237A5 JP2011531514A JP2011531514A JP2012506237A5 JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5 JP 2011531514 A JP2011531514 A JP 2011531514A JP 2011531514 A JP2011531514 A JP 2011531514A JP 2012506237 A5 JP2012506237 A5 JP 2012506237A5
Authority
JP
Japan
Prior art keywords
lip1
seq
sequence number
sign
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011531514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012506237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/063655 external-priority patent/WO2010046337A2/en
Publication of JP2012506237A publication Critical patent/JP2012506237A/ja
Publication of JP2012506237A5 publication Critical patent/JP2012506237A5/ja
Pending legal-status Critical Current

Links

JP2011531514A 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド Pending JP2012506237A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10708508P 2008-10-21 2008-10-21
US61/107,085 2008-10-21
PCT/EP2009/063655 WO2010046337A2 (en) 2008-10-21 2009-10-19 Ligands that have binding specificity for dc-sign

Publications (2)

Publication Number Publication Date
JP2012506237A JP2012506237A (ja) 2012-03-15
JP2012506237A5 true JP2012506237A5 (enExample) 2012-11-22

Family

ID=42062429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011531514A Pending JP2012506237A (ja) 2008-10-21 2009-10-19 Dc−signに対する結合特異性をもつリガンド

Country Status (16)

Country Link
US (1) US20110257373A1 (enExample)
EP (1) EP2356149A2 (enExample)
JP (1) JP2012506237A (enExample)
KR (1) KR20110071139A (enExample)
CN (1) CN102257009A (enExample)
AR (1) AR073905A1 (enExample)
AU (1) AU2009306424A1 (enExample)
BR (1) BRPI0919714A2 (enExample)
CA (1) CA2740856A1 (enExample)
EA (1) EA201100488A1 (enExample)
IL (1) IL212086A0 (enExample)
MX (1) MX2011004244A (enExample)
TW (1) TW201019962A (enExample)
UY (1) UY32189A (enExample)
WO (1) WO2010046337A2 (enExample)
ZA (1) ZA201102763B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20110775A1 (es) * 2008-10-21 2011-10-21 Domantis Ltd Composicion para dirigirse a las celulas dendriticas
EP2793918B1 (en) * 2011-12-19 2019-09-11 The Rockefeller University Hdc-sign binding peptides
US20250319024A1 (en) * 2021-08-27 2025-10-16 University Of Georgia Research Foundation, Inc. Targeted nanoparticles and their uses related to infectious disease
CN118184795B (zh) * 2022-12-13 2025-03-21 成都维瑾柏鳌生物医药科技有限公司 抗hiv-1的重组蛋白及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025686A1 (en) * 1992-06-05 1993-12-23 Baxter Diagnostics Inc. Rabbit single domain antibody and use thereof
EP3299393A1 (en) * 2002-11-08 2018-03-28 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
NZ540771A (en) * 2003-01-10 2009-05-31 Ablynx Nv Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen
EP2357237A1 (en) * 2003-05-14 2011-08-17 Domantis Limited A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire
DK1639011T3 (da) * 2003-06-30 2009-02-16 Domantis Ltd Pegylerede enkelt-domæne antistoffer (dAb)
CN102172397B (zh) * 2003-08-21 2013-01-30 利普泰克有限公司 树突细胞的体内靶向
KR20120133403A (ko) * 2004-06-01 2012-12-10 도만티스 리미티드 증강된 혈청 반감기를 가지는 이특이성 융합 항체
CA2589800A1 (en) * 2004-12-02 2006-06-08 Domantis Limited Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
KR20070086896A (ko) * 2004-12-02 2007-08-27 도만티스 리미티드 항­il­1r1 단일 도메인 항체 및 치료적 용도
CA2601115A1 (en) * 2005-03-18 2006-09-21 Domantis Limited Antibodies against candida antigens
EP1963370A1 (en) * 2005-12-06 2008-09-03 Domantis Limited Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
BRPI0619463A2 (pt) * 2005-12-06 2013-01-08 Domantis Ltd ligando, uso do mesmo, mÉtodos para tratar cÂncer e para administrar um tratamento anti-vegf e tratamento anti-egfr a um indivÍduo, composiÇço, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodo para produzir um ligando, polipeptÍdeo de domÍnio variÁvel simples de imunoglobulina, e, antagonista de egfr
AU2007209202A1 (en) * 2006-01-24 2007-08-02 Domantis Limited Ligands that bind IL-4 and/or IL-13
WO2008039432A1 (en) * 2006-09-26 2008-04-03 Alexion Pharmaceuticals, Inc. Compositions and methods for enhancing an adjuvant
WO2008070363A2 (en) * 2006-10-31 2008-06-12 Domantis Limited Intrabodies
CN101182539A (zh) * 2007-11-06 2008-05-21 浙江大学 Dc-sign启动子荧光素酶报告质粒的构建方法

Similar Documents

Publication Publication Date Title
JP6181145B2 (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
JP2013509879A5 (enExample)
JP2015212284A5 (enExample)
JP2010273685A5 (enExample)
JP2012082206A5 (enExample)
JP2005120106A5 (enExample)
JP2013531477A5 (enExample)
JP2016052315A5 (enExample)
JP2014506790A5 (enExample)
JP2013078329A5 (enExample)
JP2012095652A5 (enExample)
JP2009201525A5 (enExample)
JP2014524445A5 (enExample)
WO2011112089A3 (en) Mutated rep encoding sequences for use in aav production
JP2016000731A5 (enExample)
NZ610075A (en) Cxcr2 binding polypeptides
JP2012526530A5 (enExample)
JP2009529509A5 (enExample)
JP2014506132A5 (enExample)
JP2010227116A5 (enExample)
JP2015527366A5 (enExample)
JP2015524403A5 (enExample)
JP2007045828A5 (enExample)
JP2012506237A5 (enExample)
JP2011521653A5 (enExample)